Preliminary study on the protective effects of habitual intake of BLP on the colorectal tumors

Preliminary study on the protective effects of habitual intake of BLP on the colorectal tumors - Preliminary BLP Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025389

Enrollment

Registered

2017-03-31

Start date

2018-10-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumor (adenoma, adenocarcinoma)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Case group; The subjects who previously had at least two colorectal tumors removed, and who have been taking BLP for more than 20 years Control group; The subjects who previously had at least two colorectal tumors removed, and who have not been taking BLP and/or LcS containing products

Exclusion criteria

Exclusion criteria: In the case of treating antibiotics within 4 weeks

Design outcomes

Primary

Measure	Time frame
RNA from blood;Immunome analysis	—

Secondary

Measure	Time frame
"RNA from blood; IgA repartore analysis, PMBC; NK cell activity, Feces; IgA concentration, intestinal microbiota analysis Normal tissue of the colon; Analysis of Mucosa-Associated Commensal Bacteria"	—

Countries

Japan

Contacts

Public ContactHideki Ishikawa

Graduate School of Medical Science, Kyoto Prefectural University of Medicine Department of Molecular-Targeting Cancer Prevention

cancer@gol.com+81-6-6202-5444

Outcome results